PCI Biotech
CONTACT US
ABOUT PCI BIOTECH BOARD OF DIRECTORS MANAGEMENT COMPANY PRESENTATION
TECHNOLOGY PIPELINE PARTNERING
INVESTORS NEWS REPORTS AND PRESENTATIONS SHARE INFORMATION GENERAL MEETING INFORMATION FINANCIAL CALENDAR CORPORATE GOVERNANCE AND CSR NOMINATION COMMITTEE
ABOUT US ABOUT PCI BIOTECH BOARD OF DIRECTORS MANAGEMENT COMPANY PRESENTATION WHAT WE DO TECHNOLOGY PIPELINE PARTNERING INVESTORS INVESTORS NEWS REPORTS AND PRESENTATIONS SHARE INFORMATION GENERAL MEETING INFORMATION FINANCIAL CALENDAR CORPORATE GOVERNANCE AND CSR NOMINATION COMMITTEE CONTACT US
PCI Biotech
 

NEWS

News archive
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
 
Results from preclinical in vivo vaccination studies showing that the PCI technology can significantly improve therapeutically relevant immune responses accepted for publication
NewsadminDecember 12, 2013
Filing of patent applications for the PCI technology in vaccination
NewsadminDecember 12, 2013
Update on clinical studies – both clinical studies now open for patient inclusion.
NewsadminDecember 12, 2013
ENHANCE Study - Optimization of intra-tumour illumination and changes in patient population
NewsadminMarch 5, 2013

Privacy policy I Contact us
©COPYRIGHT PCI BIOTECH. ALL RIGHTS RESERVED